Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and sympto...
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced
About this item
Full title
Author / Creator
Ritchlin, Christopher T , Helliwell, Philip S , Boehncke, Wolf-Henning , Soriano, Enrique R , Hsia, Elizabeth C , Kollmeier, Alexa P , Chakravarty, Soumya D , Zazzetti, Federico , Subramanian, Ramanand A , Xu, Xie L , Zuraw, Qing C , Sheng, Shihong , Jiang, Yusang , Agarwal, Prasheen , Zhou, Bei , Zhuang, Yanli , Shawi, May , Karyekar, Chetan S and Deodhar, Atul
Publisher
England: EULAR
Journal title
Language
English
Formats
Publication information
Publisher
England: EULAR
Subjects
More information
Scope and Contents
Contents
ObjectiveEvaluation of the efficacy and safety of guselkumab, a human monoclonal antibody targeting the interleukin-23p19 subunit, in patients with psoriatic arthritis (PsA) through 1 year.MethodsAdults who met ClASsification criteria for Psoriatic ARthritis, with active disease (≥3 swollen and ≥3 tender joints; C reactive protein ≥0.3 mg/dL) despi...
Alternative Titles
Full title
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced
Authors, Artists and Contributors
Author / Creator
Helliwell, Philip S
Boehncke, Wolf-Henning
Soriano, Enrique R
Hsia, Elizabeth C
Kollmeier, Alexa P
Chakravarty, Soumya D
Zazzetti, Federico
Subramanian, Ramanand A
Xu, Xie L
Zuraw, Qing C
Sheng, Shihong
Jiang, Yusang
Agarwal, Prasheen
Zhou, Bei
Zhuang, Yanli
Shawi, May
Karyekar, Chetan S
Deodhar, Atul
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ae559d22818b49b5b84a51d05b30ba53
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ae559d22818b49b5b84a51d05b30ba53
Other Identifiers
ISSN
2056-5933
E-ISSN
2056-5933
DOI
10.1136/rmdopen-2020-001457
